SynCardia's Freedom® Portable Driver
Selected as Silver Winner at Edison Awards
World's First Wearable Power Supply for the SynCardia Total Artificial Heart
Honored as Game-Changing Innovation at the Forefront of New Product Development
TUCSON, Ariz. – May 2, 2013 – SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that its Freedom® portable driver, the world's first wearable power supply for the SynCardia temporary Total Artificial Heart, was named the 2013 Silver Winner amongst Assistive Devices in the Science/Medical category of the Edison Awards on April 25 in Chicago.
"The awards demonstrate the incredible range and pace of innovation globally and across a wide variety of industries," said Frank Bonafilia, executive director of the Edison Awards. "It is important that such excellence in innovation be widely recognized and done so in the spirit of the world's greatest inventor."
Weighing 13.5 pounds, the Freedom portable driver allows stable Total Artificial Heart patients who meet discharge criteria to wait for a matching donor heart at home and in their communities instead of in the hospital. To date, the Freedom portable driver has supported 130 patients worldwide, accounting for more than 55 patient years of support.
The Edison Awards have been recognizing and honoring the best in innovations and innovators since 1987. The awards honor game-changing innovations that are at the forefront of new product and service development, marketing and human-centered design, and are one of the highest accolades a company can receive in the name of successful innovation.
Winners were judged by a panel of more than 3,000 peers, including business executives, past winners, academics and leaders in the fields of product development, design, engineering, science and medicine. Sponsors of the 2013 Edison Awards included Nielsen, Discovery Communications, McAndrews Held & Malloy, Science Channel and USA Today.
The Freedom portable driver is CE approved for use in Europe and undergoing an FDA-approved Investigational Device Exemption (IDE) clinical study in the U.S.
CAUTION – The Freedom portable driver is an investigational device, limited by United States law to investigational use.
SynCardia Systems, Inc. in Tucson, Arizona is the privately-held owner and manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart for use as a bridge to transplant for people suffering from end-stage biventricular heart failure in which both ventricles can no longer pump enough blood for a person to survive.
More than 1,350 implants of the SynCardia Total Artificial Heart accounts for over 400 patient years of life on the device. Since January 2011 more than 400 SynCardia Hearts have been implanted.
The youngest patient to receive a SynCardia Heart was 9 years old; the oldest was 76 years old. The longest a patient has lived with a SynCardia Heart was nearly four years (1,374 days) before receiving a successful donor heart transplant September 11, 2011.
SynCardia Systems also manufactures the Freedom® portable driver, which powers the SynCardia Heart while allowing clinically stable patients to leave the hospital to live at home and in their communities. The wearable Freedom driver has been used by more than 190 patients, accounting for over 110 years of support